San Diego: Generic drug metformin is a cost-effective way to help prevent Type 2 diabetes in people at high risk of developing the chronic condition, according to a new economic analysis.The study also found that intensive lifestyle changes -- individually tailored weight loss and exercise -- have a higher cost, but are more likely to succeed, with a ratio of cost versus benefits in line with other common medical interventions such as blood pressure medication.When savings in the cost of medical care were balanced against the cost of the interventions, over a 10-year period, metformin saved $30 while the lifestyle program cost $1,500 per person, according the National Institutes of Health-funded study."I`m really stunned by these findings," said Dr. James Meigs, a physician in the clinical epidemiology unit and diabetes research unit at Massachusetts General Hospital in Boston. He said the study could revolutionize intervention guidelines for high-risk patients.Meigs, who was not involved in the study, spoke at a meeting of the American Diabetes Association, which presented the research in San Diego.
Ignoring chronic acidity may lead to cancer
Kids who survive cancer more often get new tumours